Compare Abeona Therapeutics Inc (ABEO) vs HP Inc (HPQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs HP Inc — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while HP Inc trades at $23.66 (market cap $21.00B). The key difference: HP Inc is far larger — about 56.3× Abeona Therapeutics Inc's market cap, and HP Inc pays a 5.23% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | HPQ | |
|---|---|---|
Market Cap | $373.32M | $21.00B |
Sector | Health | Technology |
52-Week High | $7.23 | $29.35 |
52-Week Low | $4.17 | $18.20 |
Enterprise Value | $228.22M | $28.16B |
Dividend Yield | — | 5.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
HPQ trades at $22.96, up 4.7% today, with strong earnings momentum as it has beaten EPS estimates for three consecutive quarters. The stock shows attractive valuation metrics with a P/E of 8.37 and P/S of 0.37, while technical indicators signal bearish momentum despite oversold RSI conditions. Recent developments include strategic AI partnerships with OpenAI and Ferrari, positioning the company for potential growth in the AI PC market.
The outlook remains cautiously optimistic with analyst consensus at $22.00, slightly below current price. Key opportunities include AI PC adoption and margin expansion, while risks involve competitive pressures and declining profit margins. Institutional sentiment leans neutral with 55% hold ratings, suggesting balanced risk-reward for value-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
